CN103505526B - 具有耐缺氧、抗疲劳和补肾壮阳作用的药物组合物及方法 - Google Patents
具有耐缺氧、抗疲劳和补肾壮阳作用的药物组合物及方法 Download PDFInfo
- Publication number
- CN103505526B CN103505526B CN201310394443.9A CN201310394443A CN103505526B CN 103505526 B CN103505526 B CN 103505526B CN 201310394443 A CN201310394443 A CN 201310394443A CN 103505526 B CN103505526 B CN 103505526B
- Authority
- CN
- China
- Prior art keywords
- weight portion
- radix
- crude drug
- extract
- concentrated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 108
- 210000003734 kidney Anatomy 0.000 title claims abstract description 50
- 206010021143 Hypoxia Diseases 0.000 title claims abstract description 37
- 206010002660 Anoxia Diseases 0.000 title claims abstract description 33
- 241000976983 Anoxia Species 0.000 title claims abstract description 33
- 230000007953 anoxia Effects 0.000 title claims abstract description 33
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 229940079593 drug Drugs 0.000 title claims description 88
- 230000006870 function Effects 0.000 title abstract description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 39
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 39
- 235000008434 ginseng Nutrition 0.000 claims abstract description 39
- 239000009636 Huang Qi Substances 0.000 claims abstract description 36
- 241000756943 Codonopsis Species 0.000 claims abstract description 34
- 239000006187 pill Substances 0.000 claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 24
- 239000002775 capsule Substances 0.000 claims abstract description 19
- 239000003826 tablet Substances 0.000 claims abstract description 16
- 239000007924 injection Substances 0.000 claims abstract description 12
- 238000002347 injection Methods 0.000 claims abstract description 12
- 239000002245 particle Substances 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 161
- 239000008194 pharmaceutical composition Substances 0.000 claims description 90
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 74
- 239000000284 extract Substances 0.000 claims description 66
- 238000010992 reflux Methods 0.000 claims description 50
- 238000000605 extraction Methods 0.000 claims description 47
- 238000002156 mixing Methods 0.000 claims description 43
- 239000000706 filtrate Substances 0.000 claims description 40
- 239000007788 liquid Substances 0.000 claims description 40
- 241000208340 Araliaceae Species 0.000 claims description 38
- 238000010298 pulverizing process Methods 0.000 claims description 34
- 239000000243 solution Substances 0.000 claims description 34
- 241001251068 Formica fusca Species 0.000 claims description 33
- 241000180649 Panax notoginseng Species 0.000 claims description 33
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 33
- 230000008093 supporting effect Effects 0.000 claims description 22
- 238000007654 immersion Methods 0.000 claims description 21
- -1 reflux Substances 0.000 claims description 19
- 238000003809 water extraction Methods 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 16
- 239000008187 granular material Substances 0.000 claims description 15
- 239000006286 aqueous extract Substances 0.000 claims description 12
- 239000006196 drop Substances 0.000 claims description 10
- 239000002671 adjuvant Substances 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000012567 medical material Substances 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 239000006188 syrup Substances 0.000 claims description 4
- 235000020357 syrup Nutrition 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 229960004793 sucrose Drugs 0.000 claims description 3
- 238000009495 sugar coating Methods 0.000 claims description 3
- 239000012669 liquid formulation Substances 0.000 claims description 2
- 238000005728 strengthening Methods 0.000 claims description 2
- 230000007812 deficiency Effects 0.000 abstract description 20
- 239000000463 material Substances 0.000 abstract description 4
- 231100000419 toxicity Toxicity 0.000 abstract description 4
- 230000001988 toxicity Effects 0.000 abstract description 4
- 244000131316 Panax pseudoginseng Species 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241001165494 Rhodiola Species 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 238000007796 conventional method Methods 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 70
- 241000700159 Rattus Species 0.000 description 29
- 206010016256 fatigue Diseases 0.000 description 26
- 241000699666 Mus <mouse, genus> Species 0.000 description 21
- 238000012360 testing method Methods 0.000 description 21
- 208000031975 Yang Deficiency Diseases 0.000 description 19
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 14
- 210000000056 organ Anatomy 0.000 description 14
- 230000009182 swimming Effects 0.000 description 13
- 201000010653 vesiculitis Diseases 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 12
- 229910052760 oxygen Inorganic materials 0.000 description 12
- 239000001301 oxygen Substances 0.000 description 12
- 210000002966 serum Anatomy 0.000 description 12
- 230000037396 body weight Effects 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical group C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 230000036284 oxygen consumption Effects 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 210000004907 gland Anatomy 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 230000013011 mating Effects 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 229960003604 testosterone Drugs 0.000 description 7
- 238000003304 gavage Methods 0.000 description 6
- 229940090044 injection Drugs 0.000 description 6
- 210000002307 prostate Anatomy 0.000 description 6
- 210000001625 seminal vesicle Anatomy 0.000 description 6
- 210000001550 testis Anatomy 0.000 description 6
- 206010003549 asthenia Diseases 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 230000006735 deficit Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 231100000682 maximum tolerated dose Toxicity 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000029058 respiratory gaseous exchange Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 238000012449 Kunming mouse Methods 0.000 description 4
- 230000004099 anaerobic respiration Effects 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000002085 persistent effect Effects 0.000 description 4
- 206010002091 Anaesthesia Diseases 0.000 description 3
- 201000006474 Brain Ischemia Diseases 0.000 description 3
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 3
- 206010008120 Cerebral ischaemia Diseases 0.000 description 3
- 241001411320 Eriogonum inflatum Species 0.000 description 3
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 206010008118 cerebral infarction Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000003163 gonadal steroid hormone Substances 0.000 description 3
- 230000007954 hypoxia Effects 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000018052 penile erection Effects 0.000 description 3
- 229960002275 pentobarbital sodium Drugs 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 229960003712 propranolol Drugs 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241000270728 Alligator Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 235000019082 Osmanthus Nutrition 0.000 description 2
- 241000333181 Osmanthus Species 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000009986 erectile function Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 229940010073 hydrocortisone injection Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 210000003899 penis Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 230000000384 rearing effect Effects 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 206010038669 Respiratory arrest Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000002225 anti-radical effect Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007159 enucleation Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000010437 erythropoiesis Effects 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 238000009806 oophorectomy Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000036581 peripheral resistance Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310394443.9A CN103505526B (zh) | 2013-08-30 | 2013-08-30 | 具有耐缺氧、抗疲劳和补肾壮阳作用的药物组合物及方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310394443.9A CN103505526B (zh) | 2013-08-30 | 2013-08-30 | 具有耐缺氧、抗疲劳和补肾壮阳作用的药物组合物及方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103505526A CN103505526A (zh) | 2014-01-15 |
CN103505526B true CN103505526B (zh) | 2015-06-03 |
Family
ID=49889299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310394443.9A Active CN103505526B (zh) | 2013-08-30 | 2013-08-30 | 具有耐缺氧、抗疲劳和补肾壮阳作用的药物组合物及方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103505526B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109182032A (zh) * | 2018-10-10 | 2019-01-11 | 文山学院 | 一种缓解体力疲劳的三七黄精山茱萸石斛保健酒 |
CN109999124A (zh) * | 2019-05-09 | 2019-07-12 | 参之道(通化)生物科技有限公司 | 一种黑人参鹿鞭片配方及其制备方法 |
CN114287621A (zh) * | 2021-12-28 | 2022-04-08 | 云南省药物研究所 | 一种具有缓解体力疲劳作用的组合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1528400A (zh) * | 2003-10-17 | 2004-09-15 | 广西半宙制药股份有限公司 | 一种治疗病后体虚、老年体弱的口服液 |
CN1686396A (zh) * | 2005-04-11 | 2005-10-26 | 王奉友 | 具有耐缺氧功能的保健品 |
CN1724029A (zh) * | 2005-07-22 | 2006-01-25 | 高忠元 | 一种具有补肾、滋阴壮阳功能的保健药酒及其制备方法 |
-
2013
- 2013-08-30 CN CN201310394443.9A patent/CN103505526B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1528400A (zh) * | 2003-10-17 | 2004-09-15 | 广西半宙制药股份有限公司 | 一种治疗病后体虚、老年体弱的口服液 |
CN1686396A (zh) * | 2005-04-11 | 2005-10-26 | 王奉友 | 具有耐缺氧功能的保健品 |
CN1724029A (zh) * | 2005-07-22 | 2006-01-25 | 高忠元 | 一种具有补肾、滋阴壮阳功能的保健药酒及其制备方法 |
Non-Patent Citations (2)
Title |
---|
抗运动性疲劳中药研究现状;杜朝辉等;<<中国运动医学杂志>>;20080331;第27卷(第2期);260-265 * |
近十年来国内抗衰老药的研究进展;陈新谦;<<中国药学杂志>>;19950930;第30卷(第9期);515-518 * |
Also Published As
Publication number | Publication date |
---|---|
CN103505526A (zh) | 2014-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102845749B (zh) | 一种具有改善睡眠和辅助改善记忆功能的保健组合物 | |
CN101953899B (zh) | 一种益肾壮阳的中药组合物 | |
CN101164586A (zh) | 一种治疗阳痿的药物组合物及其制备方法 | |
CN106361964A (zh) | 一种改善睡眠质量的中药组合物及其制备方法和应用 | |
CN104027529A (zh) | 一种调节血脂、血压、血糖的中药组合物及其制备方法 | |
CN103520505B (zh) | 一种治疗神经衰弱的中药制剂及制备方法 | |
CN103505526B (zh) | 具有耐缺氧、抗疲劳和补肾壮阳作用的药物组合物及方法 | |
CN101708262B (zh) | 一种治疗痛经的中药组合物胶囊及其制备方法 | |
CN103536757A (zh) | 一种具有补肾填精、益气养血和固本培元作用的中药组合物及其制备方法和应用 | |
CN101721646B (zh) | 一种治疗肾阳虚的药物组合物及其制备方法 | |
CN103301178B (zh) | 预防和治疗疲劳综合症的口服药物 | |
CN105943651A (zh) | 一种治疗卵巢早衰的中药组合物及其应用 | |
CN103223080B (zh) | 一种用于养心安神的中药组合物及其制备方法 | |
CN101732566A (zh) | 一种补肝肾强筋骨的中药复方制剂 | |
CN101444583A (zh) | 一种用于治疗神经衰弱的药物及其制备方法 | |
CN101642502B (zh) | 雄蛾壮阳复方制剂配方及其制造工艺 | |
CN103479783A (zh) | 一种治疗更年期抑郁症的中药组合物及其应用 | |
CN100446792C (zh) | 一种改善记忆的中药 | |
CN104740283A (zh) | 治疗失眠症的安神益智胶囊及其制备方法 | |
CN100509019C (zh) | 巴戟胶囊在制备增强免疫药物中的应用 | |
CN1242766C (zh) | 一种预防和治疗慢性疲劳综合症的药物及其制备方法 | |
CN102727730B (zh) | 治疗男性不育的复方中药制剂及其制备方法 | |
CN108186821A (zh) | 一种治疗神经性头痛的中药组合物及其制备方法和用途 | |
CN101244127B (zh) | 用于治疗血管性痴呆症的药物 | |
CN101264302A (zh) | 一种中药组合物在制备治疗月经不调和痛经药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200828 Address after: No.99 Haiyan Road, Lingcheng Town, Lingshan County, Qinzhou City, Guangxi Zhuang Autonomous Region Patentee after: Guangxi dalishen Pharmaceutical Co.,Ltd. Address before: 535000 No. 2 Jinqiao street, the Guangxi Zhuang Autonomous Region, Qinzhou Patentee before: Liang Wei |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Pharmaceutical composition and method with anti hypoxia, anti fatigue, tonifying kidney and strengthening yang Effective date of registration: 20211228 Granted publication date: 20150603 Pledgee: Bank of Guilin Co.,Ltd. Qinzhou branch Pledgor: Guangxi dalishen Pharmaceutical Co.,Ltd. Registration number: Y2021450000079 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20150603 Pledgee: Bank of Guilin Co.,Ltd. Qinzhou branch Pledgor: Guangxi dalishen Pharmaceutical Co.,Ltd. Registration number: Y2021450000079 |